Literature DB >> 14627362

Pure red cell aplasia associated with parvovirus B19 infection in a patient with ulcerative colitis.

Hajime Isomoto1, Yasuhiro Fukuda, Yumiko Bando, Ikuko Machida, Haruhisa Machida, Katsuhisa Omagari, Yohei Mizuta, Kunihiko Murase, Takuya Fukushima, Ikuo Murata, Shigeru Kohno.   

Abstract

Anemia is a common problem that results from various causes in patients with ulcerative colitis (UC), but there is little information on the association of UC with pure red cell aplasia (PRCA). We describe the first case of parvovirus-induced PRCA in UC. A 28-year-old woman with chronic UC was admitted to the hospital for treatment of active pancolitis. Three courses of pulse therapy with methylprednisolone provided complete remission. However, the patient developed reticulocytopenia and a subsequent fall in hemoglobin to 6.2 g/dl. Bone marrow examination revealed selective aplasia of red cell precursors and giant pronoromoblasts. Enzyme immunoassay identified specific immunoglobulin M antibody against parvovirus B19 in the serum. Based on these findings, the diagnosis of PRCA caused by the virus was made. The patient was treated with a 3-day course of intravenous immunoglobulin (5 g/day), resulting in brisk reticulocytosis, folowed by normalization of hemoglobin level. In conclusion, Chronic or acute blood loss in UC associated with enhanced red cell turnover might be a risk factor for PRCA when affected patients contract parvovirus B19 infection.

Entities:  

Mesh:

Year:  2003        PMID: 14627362     DOI: 10.1023/a:1026163530455

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  13 in total

Review 1.  Pure red cell aplasia.

Authors:  P Fisch; R Handgretinger; H E Schaefer
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

Review 2.  Drug-induced pure red cell aplasia.

Authors:  D F Thompson; M A Gales
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

3.  Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.

Authors:  G Kurtzman; N Frickhofen; J Kimball; D W Jenkins; A W Nienhuis; N S Young
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

Review 4.  Acquired pure red cell aplasia.

Authors:  S S Ammus; A A Yunis
Journal:  Am J Hematol       Date:  1987-03       Impact factor: 10.047

5.  Pure red cell aplasia associated with sulphasalazine.

Authors:  A M Dunn; G D Kerr
Journal:  Lancet       Date:  1981-12-05       Impact factor: 79.321

6.  Pure-red-cell aplasia associated with sulphasalazine but not 5-aminosalicylic acid.

Authors:  P M Anttila; M Välimäki; P J Pentikäinen
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

7.  Human parvovirus B19 infection among hospital staff members after contact with infected patients.

Authors:  L M Bell; S J Naides; P Stoffman; R L Hodinka; S A Plotkin
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

Review 8.  Auto-immune haemolytic anaemia in ulcerative colitis.

Authors:  R Ramakrishna; A Manoharan
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

9.  Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.

Authors:  N Frickhofen; Z J Chen; N S Young; B J Cohen; H Heimpel; J L Abkowitz
Journal:  Br J Haematol       Date:  1994-08       Impact factor: 6.998

10.  [Human parvovirus B19-induced aplastic crisis in an elderly man with intestinal hemorrhage].

Authors:  M Kamoshita; K Ohtani; Y Hasegawa; Y Satoh; H Kozima; A Shibuya; H Ninomiya; T Nagasawa; Y Matsunaga; T Abe
Journal:  Rinsho Ketsueki       Date:  1993-04
View more
  1 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.